Nath Bio-Genes (India) Q2 Results 2026: PAT ₹0 Cr (−84.7% YoY)
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
- Revenue
- ₹41Cr
- −7.1% YoY
- −87.6% QoQ
- Net profit
- ₹0Cr
- −84.7% YoY
- −98.7% QoQ
- Margin
- 11.36%
- −2.6 pp YoY
- +0.7 pp QoQ
Top 10 Agricultural Food & other Products companies on management guidance
See the sector's top 10 — free with your mobile number.
Nath Bio-Genes (India) Ltd Q2 FY27 key numbers
- Revenue
- Revenue from operations for quarter ended 30.09.2026: Rs 4,074.30 lakhs.
As stated in Nath Bio-Genes (India) Ltd's Q2 FY27 results statement · published 15 Nov 2026. Reported figures, not investment advice.
Based on Nath Bio-Genes (India) Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Revenue from operations for quarter ended 30.09.2026: Rs 4,074.30 lakhs. EBITDA for the quarter ended 30/09/2026: ₹553.05 Lakhs.
From Nath Bio-Genes (India) Ltd's Q2 FY27 earnings-call transcript · updated 15 Nov 2026.
How did Nath Bio-Genes (India)'s revenue grow in the September 2026 quarter?
- Revenue from operations for quarter ended 30.09.2026: Rs 4,074.30 lakhs
- Revenue for same quarter last year (30.09.2025): Rs 4,384.96 lakhs
- Year-on-year change: Decrease of Rs 310.66 lakhs (~7.08% decline)
What happened to Nath Bio-Genes (India)'s margins in Q2 FY27?
See what Nath Bio-Genes (India) Ltd said on profitability & margins — free account, 30 seconds.
What capex is Nath Bio-Genes (India) planning?
Top-ranked in Agricultural Food & other Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Nath Bio-Genes (India) raising money or cutting debt?
See what Nath Bio-Genes (India) Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Nath Bio-Genes (India)'s order book?
See what Nath Bio-Genes (India) Ltd said on order book & pipeline — free account, 30 seconds.
Nath Bio-Genes (India) Ltd — Quarterly revenue & net profit
Nath Bio-Genes (India) Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 |
|---|---|
| Revenue | 41 |
| Operating profit (EBITDA) | 5 |
| Operating margin | 11.4% |
| Profit before tax | 1 |
| Net profit (PAT) | 0 |
| EPS (₹) | 0.22 |
Source: Nath Bio-Genes (India) Ltd's results filing to NSE (consolidated), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹41 Cr, net profit ₹0 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →More Q2 FY27 results in Agricultural Food & other Products
- Marico Q2 FY27 results
- Tata Consumer Q2 FY27 results
- Patanjali Foods Q2 FY27 results
- AWL Agri Business Q2 FY27 results
- L T Foods Q2 FY27 results
- Balrampur Chini Q2 FY27 results
- CCL Products Q2 FY27 results
- KRBL Q2 FY27 results
All Q2 FY27 results | Agricultural Food & other Products rankings
Continue your research
What Nath Bio-Genes's management said in earlier quarters
Others in Agricultural Food & other Products this season
- Shreeji Global (Q2 FY27)
Total income for H1 FY27 was ₹423.95 Cr, up 43.9% YoY (from ₹294.56 Cr in H1 FY26). Key results statement takeaways from Shreeji Global FMCG Ltd's Q2 FY27 resul
- KCK Industries (Q2 FY27)
12.22%. Key results statement takeaways from KCK Industries Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
- KN Agri Resource (Q2 FY27)
Revenue from operations for the quarter ended 30.09.2026: INR 389.59 Crores (Consolidated) and INR 389.43 Crores (Standalone). Key results statement takeaways f
- Mcleod Russel (Q2 FY27)
8,811 lakhs, increased by 248% YoY (from Rs. Key results statement takeaways from Mcleod Russel India Ltd's Q2 FY27 results statement — and how it ranks against
Potential multibaggers · Q2 FY27
Potential multibaggers in Agricultural Food & other Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Nath Bio-Genes (India) Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Nath Bio-Genes (India) Ltd Q2 FY27 results?
Nath Bio-Genes (India) reported net profit of ₹0 Cr (−84.7% YoY) on revenue of ₹41 Cr (−7.1% YoY) in Q2 FY27.
What is Nath Bio-Genes (India) Ltd share price analysis?
Nath Bio-Genes (India) Ltd currently shows a neutral. The stock trades at a P/E of 7.9 with a market cap of ₹268 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Nath Bio-Genes (India) Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
